_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType,_cellLineName
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,The PCR products were cloned in the pCR2.1-TOPO-vector (Invitrogen) and transformed into TOP-10F' cells.,0.85,Accept,Experimental Usage,TOP-10F' cells
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,We employed two ER+ NF1-deficient breast cancer models: (1) an NF1-deficient MCF7 breast cancer cell line to model sporadic breast cancer,0.95,Accept,Experimental Usage,MCF7
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"established multiple NF1-deficient cell lines of which one was chosen for this analysis, NF1-45",0.9,Accept,Development,NF1-45
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...Final baculovirus expression clones were transformed into DH10Bac cells (Thermo Fisher Scientific)...,0.9,Accept,Experimental Usage,DH10Bac cells
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...E. coli expression clones were transformed into BL21(DE3) for expression...,0.9,Accept,Experimental Usage,BL21(DE3)
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...baculoviruses were generated by transfection of bacmid DNA into Sf9 cells...,0.9,Accept,Experimental Usage,Sf9 cells
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...Titered viruses were used at a multiplicity of infection of 3 to infect Tni-FNL cells...,0.9,Accept,Experimental Usage,Tni-FNL cells
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...An NF1-null HEK293T cell line was generated using CRISPR to knock out both alleles of NF1...,0.95,Accept,Development,NF1-null HEK293T cell line
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...HEK293T and NF1-null 293T cells were maintained in DMEM with 10% fetal bovine serum...,0.9,Accept,Experimental Usage,HEK293T
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"The human NF1 MPNST cell line S462TY was the gift of N. Ratner (University of Cincinnati College of Medicine, Cincinnati, OH, USA). It was derived from a xenograft of S462 cells",0.95,Accept,Experimental Usage,S462TY
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"The immortalized normal rat Schwann cell line iSC was provided by E. M. Shooter (Stanford University, Stanford, CA, USA)",0.85,Accept,Experimental Usage,iSC
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"The MPNST cell line ST88-14 was obtained from T. Glover (University of Michigan, Ann Arbor, MI, USA)",0.95,Accept,Experimental Usage,ST88-14
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,"Immortalized NF1 patient derived Schwann cell (NF SC, NF-/-) line, ipNF 95.11b and Wild type Schwann cell (WT SC, NF+/+) line, ipn 02.8 were utilized for all experiments",0.9,Accept,Experimental Usage,ipNF 95.11b
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,"Immortalized NF1 patient derived Schwann cell (NF SC, NF-/-) line, ipNF 95.11b and Wild type Schwann cell (WT SC, NF+/+) line, ipn 02.8 were utilized for all experiments",0.9,Accept,Experimental Usage,ipn 02.8
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,"We used a murine NF2 −/− Schwann cell line (we obtained this as a gift from X. Breakefield, Massachusetts General Hospital) in our study.",0.9,Accept,Experimental Usage,murine NF2 −/− Schwann cell line
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,human HEI-193 schwannoma cells in nude mice...We have successfully grown human HEI-193 in nude mice by following the same procedure.,0.9,Accept,Experimental Usage,HEI-193 cell line
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,We performed a genome-wide CRISPR/Cas9-based knockout screen of P53-null mouse embryonic liver progenitor cells that overexpressed MYC,0.85,Accept,Experimental Usage,p53−/− mouse embryonic liver progenitor cells
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,293fs cells were used to package lentivirus encoding individual sgRNA and Cas9,0.8,Accept,Experimental Usage,293fs cells
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,KrasG12D;shp53 mouse cholangiocarcinoma was generated using KrasLSL-G12D/+ liver progenitor cells which express endogenous level of KrasG12D,0.85,Accept,Experimental Usage,KrasLSL-G12D/+ liver progenitor cells
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"mutant transcripts were expressed in HEK-293T cells. The phosphorylation level of ELK1, which is a downstream substrate of the RAS/MAPK pathway",0.9,Accept,Experimental Usage,HEK-293T cells
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,"HEK 293T and immortalized mouse Nf2 Schwann cells, a gift from D. Lallemand...were maintained in Dulbecco's minimum essential medium",0.9,Accept,Experimental Usage,HEK 293T
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,"HEK 293T and immortalized mouse Nf2 Schwann cells, a gift from D. Lallemand (Centre National de la Recherche Scientifique, Institut Curie, Paris, France)",0.95,Accept,Experimental Usage,immortalized mouse Nf2 Schwann cells
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,"HEK 293 T and COS-7 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM)...To investigate the NF-SPRED interaction, FLAG-SPRED1 (WT or variant) and NF (WT or variant) were coexpressed in HEK 293 T cells",0.9,Accept,Experimental Usage,HEK 293T cells
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,HEK 293 T and COS-7 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM)...HA-H-RAS was expressed together with either wild-type (WT) or variant NF in COS-7 or HEK 293 T cells,0.9,Accept,Experimental Usage,COS-7 cells
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,"Nf1 −/− , Nf1 +/− , and wildtype mouse embryo fibroblasts were generated as previously described ( 15 ).",0.9,Accept,Experimental Usage,Nf1−/− mouse embryo fibroblasts
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,"Nf1 −/− , Nf1 +/− , and wildtype mouse embryo fibroblasts were generated as previously described ( 15 ).",0.9,Accept,Experimental Usage,Nf1+/− mouse embryo fibroblasts
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,"We have previously described the source of T265-2c cells, ST88-14 cells and 90-8 cells, the human NF1-associated MPNST lines used in this study",0.9,Accept,Experimental Usage,T265-2c cells
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,"We have previously described the source of T265-2c cells, ST88-14 cells and 90-8 cells, the human NF1-associated MPNST lines used in this study",0.9,Accept,Experimental Usage,ST88-14 cells
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,"We have previously described the source of T265-2c cells, ST88-14 cells and 90-8 cells, the human NF1-associated MPNST lines used in this study",0.9,Accept,Experimental Usage,90-8 cells
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,"MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained",0.95,Accept,Experimental Usage,NF96.2
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,"MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained",0.95,Accept,Experimental Usage,NF02.2
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,"MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained",0.95,Accept,Experimental Usage,NF94.3
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,...HEK293 cells (6 × 10 5 ) were transfected with 1 µg of the wild type or the mutated minigene...,0.9,Accept,Experimental Usage,HEK293 cells
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"In vitro design validation was performed using a porcine kidney epithelial cell line (LLC-PK1 ATCC CL-101 ™ ; American Type Culture Collection (ATCC), Manassas, VA)",0.9,Accept,Experimental Usage,LLC-PK1 ATCC CL-101
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"Human PDAC cell lines MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 were acquired from American Type Culture Collection (ATCC, Rockville, MD, USA)",0.9,Accept,Experimental Usage,MIAPaCa-2
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"Human PDAC cell lines MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 were acquired from American Type Culture Collection (ATCC, Rockville, MD, USA)",0.9,Accept,Experimental Usage,Panc-1
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"Human PDAC cell lines MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 were acquired from American Type Culture Collection (ATCC, Rockville, MD, USA)",0.9,Accept,Experimental Usage,BxPC-3
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"Human PDAC cell lines MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 were acquired from American Type Culture Collection (ATCC, Rockville, MD, USA)",0.9,Accept,Experimental Usage,AsPC-1
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,"Immortalized human pancreatic ductal epithelial (HPDE H6c7) cells were a kind gift from Dr. Ming-Sound Tsao at Ontario Cancer Institute, Toronto, Canada",0.9,Accept,Experimental Usage,HPDE H6c7
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Human cell lines included an NF2-null immortalized MN line Ben-Men-1,0.95,Accept,Experimental Usage,Ben-Men-1
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"NF2 AC-CRISPR, and two independent human primary MN for which cell line establishment",0.9,Accept,Experimental Usage,AC-CRISPR
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"we generated an immortalized human MN line, MN1-LF from an independent NF2-null human primary MN",0.9,Accept,Experimental Usage,MN1-LF
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"Immortalized human pNF cell lines pNF9511bc and ipNF03.3, immortalized human normal Schwann cell line ipn023λ, were generated by the Wallace's lab",0.9,Accept,Experimental Usage,pNF9511bc
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"Immortalized human pNF cell lines pNF9511bc and ipNF03.3, immortalized human normal Schwann cell line ipn023λ, were generated by the Wallace's lab",0.9,Accept,Experimental Usage,ipNF03.3
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"Immortalized human pNF cell lines pNF9511bc and ipNF03.3, immortalized human normal Schwann cell line ipn023λ, were generated by the Wallace's lab",0.9,Accept,Experimental Usage,ipn023λ
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"Human MPNST cell line ST88-14, S462 and a patient-derived xenoline RHT92 were kindly provided by Melissa L. Fishel at the Indiana University School of Medicine",0.95,Accept,Experimental Usage,ST88-14
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"Human MPNST cell line ST88-14, S462 and a patient-derived xenoline RHT92 were kindly provided by Melissa L. Fishel at the Indiana University School of Medicine",0.95,Accept,Experimental Usage,S462
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,The NF1-deficient LN229 glioma cell line was kindly provided by Karisa Schreck of the Johns Hopkins University,0.9,Accept,Experimental Usage,LN229
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"FiPS, a WT human iPSC line derived from fibroblast, and its isogenic NF1 iPSC generated by CRISPR (NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12, Sex: XY)",0.9,Accept,Experimental Usage,FiPS
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"FiPS, a WT human iPSC line derived from fibroblast, and its isogenic NF1 iPSC generated by CRISPR (NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12, Sex: XY)",0.95,Accept,Experimental Usage,NF1−/−−/− edited FiPS Ctrl1-SV4F-7
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"as well as the pNF-derived NF1−/− iPSC 3MM (3PNF_SiPSsv_MM_11, Sex: XX), were obtained from the Spanish Stem Cell Biobank",0.9,Accept,Experimental Usage,3PNF_SiPSsv_MM_11
PMID:21111000,10.1016/j.jneumeth.2010.10.021,A novel imaging-compatible sciatic nerve schwannoma model.,,Human schwannoma cell line HEI-193 was established from a benign schwannoma tumor from an NF2 patient immortalized with retroviral mediated HPV E6-E7 gene expression,0.95,Accept,Experimental Usage,HEI-193
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Human meningeal cells (HMC) were obtained from Sciencell™ and maintained in the manufacturer's recommended media at 5% CO2,0.85,Accept,Experimental Usage,Human meningeal cells (HMC) from Sciencell™
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"Ben-Men-1 cells and primary meningioma cells were routinely grown in DMEM, 10% FBS and 100 U/ml Penicillin/Streptomycin",0.9,Accept,Experimental Usage,Ben-Men-1 cells
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,Primary Schwann cells were purified from sciatic nerve from postnatal day 1 rats as described previously,0.8,Accept,Experimental Usage,Primary Schwann cells
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,Fibroblasts from E12.5 mouse embryos were obtained when embryos were dissected for DRG preparation,0.9,Accept,Experimental Usage,Nf1 mouse fibroblasts
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,...we examined the association between gene expression in lymphoblastoid cell lines with NF1-associated phenotypes...,0.85,Accept,Experimental Usage,lymphoblastoid cell lines
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"Human immortalized NF1 −/− Schwann cells (iPNF95.6) were plated in triplicate at a density of 5,000 cells/well",0.9,Accept,Experimental Usage,iPNF95.6
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"OLN93 mouse oligodendrocyte cell line was kindly provided by Dr. C. Richter-Landsberg (Oldenburg University, Germany)",0.9,Accept,Experimental Usage,OLN93 mouse oligodendrocyte cell line
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,SC4-immortalized Nf2-/- primary Schwann cells were derived from Nf2-/- deficient mice,0.95,Accept,Experimental Usage,SC4-immortalized Nf2-/- primary Schwann cells
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"The RT4-D6PT2 schwannoma cell line was obtained from the European Collection of Animal Cell Cultures (Salisbury, United Kingdom)",0.9,Accept,Experimental Usage,RT4-D6PT2 schwannoma cell line
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"The TC620 human oligodendroglioma cell line was a gift from Dr. A. Glassmann (Life Science Incubators, EPN-Technology, Germany)",0.9,Accept,Experimental Usage,TC620 human oligodendroglioma cell line
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Normal human Schwann cells (NHSC) from trauma victims and MPNST cell lines were cultured as described,0.9,Accept,Experimental Usage,Normal human Schwann cells (NHSC)
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Normal human Schwann cells (NHSC) from trauma victims and MPNST cell lines were cultured as described,0.85,Accept,Experimental Usage,MPNST cell lines
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,MPNST 88-14 cells were cross-linked with 1% formaldehyde for 10 minutes on ice,0.9,Accept,Experimental Usage,MPNST 88-14 cells
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,1.5 ×10 6 MPNST S462-TY cells suspended in Matrigel (BD) and expressing pLVX control or inducible-MAF,0.9,Accept,Experimental Usage,MPNST S462-TY cells
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,cells were seeded at 1.0 × 104 (S462 cell-line) or 3.0 × 104 (2884 and 2885 cell-lines) cells/well in 24-well culture plates,0.85,Accept,Experimental Usage,S462 cell-line
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,cells were seeded at 1.0 × 104 (S462 cell-line) or 3.0 × 104 (2884 and 2885 cell-lines) cells/well,0.85,Accept,Experimental Usage,2884 cell-line
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,cells were seeded at 1.0 × 104 (S462 cell-line) or 3.0 × 104 (2884 and 2885 cell-lines) cells/well,0.85,Accept,Experimental Usage,2885 cell-line
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"ipn97.4 immortalized human Schwann cells were obtained from Peggy Wallace. To create an isogenic NF1 null cell line, we utilized CRISPR Cas9 targeting...",0.9,Accept,Experimental Usage,ipn97.4 immortalized human Schwann cells
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Ossabaw minipig fetal fibroblasts isolated from day 38 embryos were transfected with TALENs and a 90-mer homology-directed repair (HDR) template,0.9,Accept,Experimental Usage,Ossabaw minipig fetal fibroblasts
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Optic glioma cells were isolated from the optic nerves of three-month-old Nf1^OPG mice,0.85,Accept,Experimental Usage,optic glioma cells
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Immortalized human Schwann cell (HSC1λ) and immortalized neurofibroma cell (ipNF06.2A) were obtained from Dr. Margaret Wallace's laboratory,0.9,Accept,Experimental Usage,HSC1λ
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Immortalized human Schwann cell (HSC1λ) and immortalized neurofibroma cell (ipNF06.2A) were obtained from Dr. Margaret Wallace's laboratory,0.9,Accept,Experimental Usage,ipNF06.2A
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"MPNST cell lines (STS-26T, S462, S462TY, T265) were obtained from Dr. David Largaespada's laboratory",0.9,Accept,Experimental Usage,STS-26T
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"MPNST cell lines (STS-26T, S462, S462TY, T265) were obtained from Dr. David Largaespada's laboratory",0.9,Accept,Experimental Usage,S462
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"MPNST cell lines (STS-26T, S462, S462TY, T265) were obtained from Dr. David Largaespada's laboratory",0.9,Accept,Experimental Usage,S462TY
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"MPNST cell lines (STS-26T, S462, S462TY, T265) were obtained from Dr. David Largaespada's laboratory",0.9,Accept,Experimental Usage,T265
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"pLKO.1 plasmid was co-transfected with pMDLg/pRRE, pRSV-REV and pCMV-VSV-G into HEK293T cells using the FuGENEHD transfection reagent",0.85,Accept,Experimental Usage,HEK293T
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"Cultured immortalized Schwann cells (iHSC1λ and iHSC2λ) were both derived from a patient's normal sciatic nerve, are NF1 wild-type, and were immortalized by hTERT and CDK4",0.9,Accept,Experimental Usage,iHSC1λ
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"Cultured immortalized Schwann cells (iHSC1λ and iHSC2λ) were both derived from a patient's normal sciatic nerve, are NF1 wild-type, and were immortalized by hTERT and CDK4",0.9,Accept,Experimental Usage,iHSC2λ
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 ))",0.85,Accept,Experimental Usage,S462
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 ))",0.85,Accept,Experimental Usage,S462-TY
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 ))",0.85,Accept,Experimental Usage,ST8814
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 ))",0.85,Accept,Experimental Usage,T265
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"Immortalized human Schwann cell and MPNST cell lines (S462 ( 45 ), S462-TY ( 35 ), ST8814 ( 46 ), T265 ( 47 ), and STS-26T ( 36 ))",0.85,Accept,Experimental Usage,STS-26T
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,NF1-1 and NF1-2 hiPSC lines were reprogrammed using OSKM episomal technique by Phenocell from two patient-derived fibroblasts carrying NF1 mutations,0.9,Accept,Experimental Usage,NF1-1 and NF1-2 hiPSC lines
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Two control NF1 (+/+) hiPSC lines (WT-1 and WT-2) purchased from Phenocell were also generated from control donors,0.9,Accept,Experimental Usage,WT-1 and WT-2 control hiPSC lines
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,"TOPO™ TA Cloning™ Kit for Sequencing, with One Shot™ TOP10 Chemically Competent E. coli (Thermo Fisher Scientific)",0.8,Accept,Experimental Usage,One Shot TOP10 Chemically Competent E. coli
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"HEK293T cells (American Type Culture Collection [ATCC], CRL-3216)",0.9,Accept,Experimental Usage,HEK293T cells
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,HeLa cells (ATCC CCL-2),0.9,Accept,Experimental Usage,HeLa cells
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,LUVA cells (Kerafast) were cultured in STEM PRO-34 SFM,0.9,Accept,Experimental Usage,LUVA cells
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"human fibroblasts (ATCC, PCS-201-012) were grown in DMEM",0.85,Accept,Experimental Usage,human fibroblasts
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,"The human MPNST cell line sNF96.2, was kindly provided by Dr Abhijit Guha...We confirmed the reported germline mutation in exon 21 (3683delC)",0.95,Accept,Experimental Usage,sNF96.2
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,"very-low expression of the gene in both the neurofibromas and MPNST cases compared with HEK293T cells, which are neurofibromin 1 wildtype (WT)",0.85,Accept,Experimental Usage,HEK293T
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,We confirmed the reported germline mutation in exon 21 (3683delC) and loss of the remaining WT allele in the cell line before use in our study compared with HT1080 WT,0.85,Accept,Experimental Usage,HT1080
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,...DPSCs were obtained from human third molars...Two primary cell cultures were obtained from individuals with NF1 (NF1 group; NF37 and NF87)...,0.9,Accept,Experimental Usage,NF1 DPSCs
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...three from individuals without NF1 (control group; CT10, CT11 and CT12)...",0.85,Accept,Experimental Usage,Control DPSCs
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"The original CTL BJFF.6 hiPSCs were generated from commercially available human foreskin fibroblasts (Stemgent, Reprocell, MD, USA)",0.85,Accept,Experimental Usage,CTL BJFF.6 hiPSCs
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Pooled human endothelial colony forming cells (ECFC, endothelial outgrowth cells) were purchased from the Angio BioCore at Indiana University",0.85,Accept,Experimental Usage,human endothelial colony forming cells (ECFC)
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Human microvascular endothelial cells (HMVEC) were purchased from Lonza (Allendale, NJ, USA).",0.85,Accept,Experimental Usage,human microvascular endothelial cells (HMVEC)
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"To generate lentiviral supernatant, 293FT packaging cells were plated onto tissue culture plates and transfected the following day",0.8,Accept,Experimental Usage,293FT packaging cells
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"The NF1 patient-derived HGG cell line TM-31 (RRID:CVCL_6735), purchased from the RIKEN biorepository, is null for NF1, TP53, CDKN2A and ATRX",0.95,Accept,Experimental Usage,TM-31
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,The Glioblastoma Multiphorme (GBM) LN319 cell line was a gift from Dr. Karen Cichowski. LN319 is an adult sporadic GBM with full inactivation of NF1,0.9,Accept,Experimental Usage,LN319
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model",0.9,Accept,Experimental Usage,17
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model",0.9,Accept,Experimental Usage,5653
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"Mouse NF1-HGG cell lines 17, 5653, and 5746 were derived from three distinct high-grade murine brain tumors sporadically developed by the NPcis genetically engineered mouse model",0.9,Accept,Experimental Usage,5746
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA) were maintained in culture at 37°C in an atmosphere of 5% carbon dioxide.",0.9,Accept,Experimental Usage,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)"
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,MPNST was derived from a patient with a high grade peripheral nerve sheath tumor of the thigh,0.85,Accept,Experimental Usage,MPNST cell line
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,ST8814 was derived from a patient with NF1-associated MPNST of the thigh,0.85,Accept,Experimental Usage,ST8814 cell line
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,LS141 and DDLS primary human cell lines were derived from two patients with high grade retroperitoneal dedifferentiated liposarcoma,0.8,Accept,Experimental Usage,LS141 cell line
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,LS141 and DDLS primary human cell lines were derived from two patients with high grade retroperitoneal dedifferentiated liposarcoma,0.8,Accept,Experimental Usage,DDLS cell line
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,"Human Schwann cells (HSCs) were purchased from ScienCell Research Laboratories (catalog no., 1700).",0.85,Accept,Experimental Usage,Human Schwann cells (HSCs)
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,The rat RT4-D6P2T schwannoma cells was obtained from the Global Bioresource Center.,0.85,Accept,Experimental Usage,RT4-D6P2T schwannoma cells
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,"The HEI-193, an HPV E6-E7 immortalized schwannoma cell line, was a kind gift from Dr. Weg M. Ongkeko (House Ear Institute).",0.85,Accept,Experimental Usage,HEI-193
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,The HEK 293T cell line was purchased from ATCC,0.85,Accept,Experimental Usage,HEK 293T cell line
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,LN428 human glioblastoma multiforme (GBM) cell line was a gift from Dr. Erwin van Meir,0.85,Accept,Experimental Usage,LN428 human glioblastoma multiforme (GBM) cell line
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,The C2C12 line is a subclone of a mouse myoblast cell line. These cells were purchased from the American Type Culture Collection (ATCC),0.9,Accept,Experimental Usage,C2C12
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,The following immortalized human plexiform neurofibroma cell lines ( Nf1 −/− ; hereafter called pNF1 cells) described in [ 23 ] were used: ipNF95.11b C and ipNF05.5 purchased from ATCC.,0.9,Accept,Experimental Usage,ipNF95.11b C
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,The following immortalized human plexiform neurofibroma cell lines ( Nf1 −/− ; hereafter called pNF1 cells) described in [ 23 ] were used: ipNF95.11b C and ipNF05.5 purchased from ATCC.,0.9,Accept,Experimental Usage,ipNF05.5
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,The plasmid was transformed into the E. coli strain BL21(DE3) Star (Invitrogen).,0.9,Accept,Experimental Usage,E. coli strain BL21(DE3) Star
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"Cultured immortalized Schwann cells (iHSC1λ and iHSC2λ) were both derived from a patient's normal sciatic nerve, are NF1 wild-type, and were immortalized by hTERT and CDK4 R24C",0.9,Accept,Experimental Usage,iHSC1λ
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"Cultured immortalized Schwann cells (iHSC1λ and iHSC2λ) were both derived from a patient's normal sciatic nerve, are NF1 wild-type, and were immortalized by hTERT and CDK4 R24C",0.9,Accept,Experimental Usage,iHSC2λ
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"Immortalized human Schwann cell and MPNST cell lines (S462 [34], S462-TY [35], ST8814 [36], T265 [37], and STS-26T [38]) were maintained in Dulbecco's Modification of Eagle Medium",0.85,Accept,Experimental Usage,S462
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"Immortalized human Schwann cell and MPNST cell lines (S462 [34], S462-TY [35], ST8814 [36], T265 [37], and STS-26T [38]) were maintained in Dulbecco's Modification of Eagle Medium",0.85,Accept,Experimental Usage,S462-TY
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"Immortalized human Schwann cell and MPNST cell lines (S462 [34], S462-TY [35], ST8814 [36], T265 [37], and STS-26T [38]) were maintained in Dulbecco's Modification of Eagle Medium",0.85,Accept,Experimental Usage,ST8814
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"Immortalized human Schwann cell and MPNST cell lines (S462 [34], S462-TY [35], ST8814 [36], T265 [37], and STS-26T [38]) were maintained in Dulbecco's Modification of Eagle Medium",0.85,Accept,Experimental Usage,T265
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"Immortalized human Schwann cell and MPNST cell lines (S462 [34], S462-TY [35], ST8814 [36], T265 [37], and STS-26T [38]) were maintained in Dulbecco's Modification of Eagle Medium",0.85,Accept,Experimental Usage,STS-26T
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,"...iHSCs and human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) were cultured in complete media...",0.9,Accept,Experimental Usage,ST88-14
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,"...iHSCs and human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) were cultured in complete media...",0.9,Accept,Experimental Usage,STS26T
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,"...iHSCs and human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) were cultured in complete media...",0.9,Accept,Experimental Usage,S462
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,"...iHSCs and human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) were cultured in complete media...",0.9,Accept,Experimental Usage,S462-TY
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,"...iHSCs and human MPNST cell lines (ST88-14, STS26T, S462, S462-TY, and T265) were cultured in complete media...",0.9,Accept,Experimental Usage,T265
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,...Immortalized human Schwann cells (iHSCs) were acquired from the laboratory of Dr. Margaret Wallace. iHSCs and human MPNST cell lines...,0.85,Accept,Experimental Usage,iHSCs
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,...Assembled TALENs were tested by transient transfection into K562 cells using the NEON electroporation system...,0.8,Accept,Experimental Usage,K562
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Human 293T cells (used for lentiviral packaging), sNF96.2 (a MPNST cell line derived from a patient with NF1, used as target cells)",0.9,Accept,Experimental Usage,293T cells
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"sNF96.2 (a MPNST cell line derived from a patient with NF1, used as target cells) and HFFs (human foreskin fibroblasts, used as target cells)",0.95,Accept,Experimental Usage,sNF96.2
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"HFFs (human foreskin fibroblasts, used as target cells) were maintained in DMEM (GIBCO) supplemented with 10% (v/v) FBS",0.85,Accept,Experimental Usage,HFFs
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"NCI-H266 (a lung carcinoma cell line, used as target cells) and K562 (a chronic myelogenous leukemia cell line, used as target cells)",0.85,Accept,Experimental Usage,NCI-H266
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"K562 (a chronic myelogenous leukemia cell line, used as target cells) were maintained in RPMI1640 (GIBCO)",0.85,Accept,Experimental Usage,K562
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Firefly over-expressing sNF96.2 (sNF96.2-luci, also used as target cells) was derived by lentiviral infection and puromycin selection",0.9,Accept,Development,sNF96.2-luci
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,We received iHSCs from Dr. Margaret Wallace (University of Florida). These are wild-type human SCs immortalized using the human reverse transcriptase component of telomerase,0.85,Accept,Experimental Usage,iHSCs
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,S462-TY cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C with 5% CO2,0.9,Accept,Experimental Usage,S462-TY cells
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,ST88-14 is an established NF1-deficient MPNST cell line,0.85,Accept,Experimental Usage,ST88-14
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,Human MPNST cell lines S462 and T265 were described previously...Cells were cultured in DMEM,0.9,Accept,Experimental Usage,S462
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,Human MPNST cell lines S462 and T265 were described previously...Cells were cultured in DMEM,0.9,Accept,Experimental Usage,T265
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"The establishment of the MPNST-SP-01, MPNST-NF1-08, and MPNST-NF1-9 cell lines at the Catalan Institute of Oncology is described",0.9,Accept,Experimental Usage,MPNST-SP-01
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"The establishment of the MPNST-SP-01, MPNST-NF1-08, and MPNST-NF1-9 cell lines at the Catalan Institute of Oncology is described",0.9,Accept,Experimental Usage,MPNST-NF1-08
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"The establishment of the MPNST-SP-01, MPNST-NF1-08, and MPNST-NF1-9 cell lines at the Catalan Institute of Oncology is described",0.9,Accept,Experimental Usage,MPNST-NF1-9
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories",0.85,Accept,Experimental Usage,STS-26T
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories",0.85,Accept,Experimental Usage,HS-PSS
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories",0.85,Accept,Experimental Usage,HS-sch2
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories",0.85,Accept,Experimental Usage,S462
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"STS-26T (19), HS-PSS, HS-sch2 (20), S462 (21), and sNF96.2 (22) cell lines were previously established in other laboratories",0.85,Accept,Experimental Usage,sNF96.2
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,The Human Foreskin Fibroblast (HFF) cell line was purchased from ATCC (American Type Culture Collection),0.8,Accept,Experimental Usage,Human Foreskin Fibroblast (HFF)
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"The following immortalized human plexiform neurofibroma cell lines (hereafter called pNF1 cells) described in [ 36 ] were used: ipNF95.11b C, ipNF95.11b C-RFP, and ipNF 05.5.",0.9,Accept,Experimental Usage,ipNF95.11b C
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"ipNF95.11b C gifted from Dr. Margaret Wallace (University of Florida, USA) was lentivirally transduced with red fluorescent protein (RFP) by Dr. Raymond R Mattingly's group",0.9,Accept,Experimental Usage,ipNF95.11b C-RFP
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"The following immortalized human plexiform neurofibroma cell lines (hereafter called pNF1 cells) described in [ 36 ] were used: ipNF95.11b C, ipNF95.11b C-RFP, and ipNF 05.5.",0.9,Accept,Experimental Usage,ipNF 05.5
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,Cell lines included immortalized NF2-deficient meningioma Ben-Men-1,0.9,Accept,Experimental Usage,Ben-Men-1
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,immortalized arachnoid AC007-hTERT derived from an NF2 patient expressing heterozygous level of NF2,0.9,Accept,Experimental Usage,AC007-hTERT
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,primary normal arachnoid AC028,0.85,Accept,Experimental Usage,AC028
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,Low passage 293T cells for large-scale lentiviral packaging were obtained from TRC,0.8,Accept,Experimental Usage,293T cells
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,U87-MG and HEK293T cells were purchased from ATCC. Cell lines were regularly passaged and were cultured in Dulbecco's Modified Eagle Medium,0.9,Accept,Experimental Usage,U87-MG
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,U87-MG and HEK293T cells were purchased from ATCC. Cell lines were regularly passaged and were cultured in Dulbecco's Modified Eagle Medium,0.9,Accept,Experimental Usage,HEK293T
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,FH-DCAF1 and FH-Lats1 (purified from 293T cells) were incubated in 20 μl reaction buffer,0.8,Accept,Experimental Usage,293T cells
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,plated in 0.34% low melting temperature agarose (FMC Bioproducts) in complete medium at 2×10 4 (Meso-33 cells),0.9,Accept,Experimental Usage,Meso-33 cells
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,"or 1.2×10 4 (FC-1801 cells) per well in 24-well Ultra Low Cluster Plates (Costar). For tumorigenicity assay, 1×10 6 FC-1801 cells",0.9,Accept,Experimental Usage,FC-1801 cells
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,NIH-3T3 (obtained from American Type Culture Collection) cells were cultured in high-glucose DMEM supplemented with 10% fetal calf serum,0.9,Accept,Experimental Usage,NIH-3T3
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,The φNX packaging cell line (Orbigen) was transfected using Lipofectamine 2000,0.85,Accept,Experimental Usage,φNX packaging cell line
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"H1838 was obtained from the American Type Culture Collection (ATCC, Manassas, VA)",0.9,Accept,Experimental Usage,H1838
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,WM3918 and M308 were obtained from Dr. David Solit at Memorial Sloan Kettering Cancer Center,0.9,Accept,Experimental Usage,WM3918
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,WM3918 and M308 were obtained from Dr. David Solit at Memorial Sloan Kettering Cancer Center,0.9,Accept,Experimental Usage,M308
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"STS26T, ST8814 and NF90.8 were kindly provided by Dr. Gregory Riggins at Johns Hopkins University",0.9,Accept,Experimental Usage,STS26T
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"STS26T, ST8814 and NF90.8 were kindly provided by Dr. Gregory Riggins at Johns Hopkins University",0.9,Accept,Experimental Usage,ST8814
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"STS26T, ST8814 and NF90.8 were kindly provided by Dr. Gregory Riggins at Johns Hopkins University",0.9,Accept,Experimental Usage,NF90.8
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"NF94.3, NF96.2, NF10.1 and NF11.1 were kindly provided by Dr. Margaret Wallace at University of Florida",0.9,Accept,Experimental Usage,NF94.3
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"NF94.3, NF96.2, NF10.1 and NF11.1 were kindly provided by Dr. Margaret Wallace at University of Florida",0.9,Accept,Experimental Usage,NF96.2
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"NF94.3, NF96.2, NF10.1 and NF11.1 were kindly provided by Dr. Margaret Wallace at University of Florida",0.9,Accept,Experimental Usage,NF10.1
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"NF94.3, NF96.2, NF10.1 and NF11.1 were kindly provided by Dr. Margaret Wallace at University of Florida",0.9,Accept,Experimental Usage,NF11.1
PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,"Diploid yeast deletion strains used for growth analyses were of the BY4743 background (MATa/MATα, his3∆1/his3∆1, leu2∆0/leu2∆0...)",0.85,Accept,Experimental Usage,BY4743 background diploid yeast deletion strains
PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,"The haploid yeast MORF (Movable ORF) strain for RAS1 overexpression was of the Y258 background (MATa, pep 4-3, his 4-580...)",0.85,Accept,Experimental Usage,Y258 background haploid yeast MORF strain
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,The mouse K4622 grade II glioma cell line was derived from a C57Bl/6 Nf1+/−; p53+/− mouse and was shown to be both Nf1- and p53-deficient,0.9,Accept,Experimental Usage,K4622 grade II glioma cell line
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"Primary normal human astrocytes (M059J) and 4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank",0.85,Accept,Experimental Usage,M059J
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank of the Chinese Academy of Sciences",0.85,Accept,Experimental Usage,U87
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank of the Chinese Academy of Sciences",0.85,Accept,Experimental Usage,U118
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank of the Chinese Academy of Sciences",0.85,Accept,Experimental Usage,U251
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,"4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank of the Chinese Academy of Sciences",0.85,Accept,Experimental Usage,A172
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Schwann cells from the PNF were cultured and identified as previously described. After ensuring purity of 85%, PNF-derived Schwann cells were treated with nilotinib and imatinib",0.9,Accept,Experimental Usage,PNF-derived Schwann cells
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,Wild-type and Nf1 -/- primary astrocytes were generated and maintained as previously described,0.85,Accept,Experimental Usage,Nf1 -/- primary astrocytes
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,Recombinant baculoviruses were generated according to Berger I. et al. using E. coli DH10Multibac cells containing the modified baculoviral genome,0.8,Accept,Experimental Usage,E. coli DH10Multibac cells
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,"using E. coli DH10Multibac cells containing the modified baculoviral genome and Sf21 insect cells (Life Technologies, Carlsbad, CA, USA)",0.85,Accept,Experimental Usage,Sf21 insect cells
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously",0.9,Accept,Experimental Usage,ST88-14
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously",0.9,Accept,Experimental Usage,STS26T
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously",0.9,Accept,Experimental Usage,S520
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously",0.9,Accept,Experimental Usage,S462
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously",0.9,Accept,Experimental Usage,88-3
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously",0.9,Accept,Experimental Usage,90-8
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,"We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously",0.9,Accept,Experimental Usage,YST1
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Seven primary SC cultures and their matched immortalized cell lines were chosen for genomic analysis (Table 1; icNF97.2a, icNF97.2b, icNF98.4c",0.95,Accept,Development,icNF97.2a
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Seven primary SC cultures and their matched immortalized cell lines were chosen for genomic analysis (Table 1; icNF97.2a, icNF97.2b, icNF98.4c",0.95,Accept,Development,icNF97.2b
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Seven primary SC cultures and their matched immortalized cell lines were chosen for genomic analysis (Table 1; icNF97.2a, icNF97.2b, icNF98.4c",0.95,Accept,Development,icNF98.4c
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Seven primary SC cultures and their matched immortalized cell lines were chosen for genomic analysis (Table 1; icNF97.2a, icNF97.2b, icNF98.4c, icNF98.4d",0.95,Accept,Development,icNF98.4d
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Seven primary SC cultures and their matched immortalized cell lines were chosen for genomic analysis (Table 1; icNF97.2a, icNF97.2b, icNF98.4c, icNF98.4d, icNF00.10a",0.95,Accept,Development,icNF00.10a
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Seven primary SC cultures and their matched immortalized cell lines were chosen for genomic analysis (Table 1; icNF97.2a, icNF97.2b, icNF98.4c, icNF98.4d, icNF00.10a, icNF04.9a",0.95,Accept,Development,icNF04.9a
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Seven primary SC cultures and their matched immortalized cell lines were chosen for genomic analysis (Table 1; icNF97.2a, icNF97.2b, icNF98.4c, icNF98.4d, icNF00.10a, icNF04.9a, i28cNF)",0.95,Accept,Development,i28cNF
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"The three other additional lines (i18cNF, i21cNF, i28cNF) were from NF1 cNFs obtained and cultured with approval of the Clinical Research Ethics Committee",0.9,Accept,Development,i18cNF
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"The three other additional lines (i18cNF, i21cNF, i28cNF) were from NF1 cNFs obtained and cultured with approval of the Clinical Research Ethics Committee",0.9,Accept,Development,i21cNF
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,icNF18.1a F pedunculated c.4084C > T p.Arg1362Ter (strong NMD) low level of c.92A > G p.His31Arg (mostly heterozygous),0.9,Accept,Development,icNF18.1a
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,icNF09.5 F pedunculated c.4084C > T p.Arg1362Ter (strong NMD) none detected (= heterozygous?),0.9,Accept,Development,icNF09.5
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,icNF93.1a F pedunculated c.2350T > C p.Trp784Arg none detected (= heterozygous?),0.9,Accept,Development,icNF93.1a
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,icNF97.5 M flat or sub-cutaneous c.8160G > C p.Thr2720 = (silent) none detected (= heterozygous?),0.9,Accept,Development,icNF97.5
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,icNF99.1 F globular c.1246C > T p.Arg416Ter c.6888G > A p.Trp2296Ter low level (mostly heterozygous?),0.9,Accept,Development,icNF99.1
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,Several cell lines derived from MPNSTs were used: S462 and ST88-14 (provided by Dr Nancy Ratner),0.9,Accept,Experimental Usage,S462
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,Several cell lines derived from MPNSTs were used: S462 and ST88-14 (provided by Dr Nancy Ratner),0.9,Accept,Experimental Usage,ST88-14
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,sNF96.2 (provided by Dr Thomas De Raedt),0.9,Accept,Experimental Usage,sNF96.2
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,90-8 and the sporadic MPNST-derived STS-26T (provided by Dr Eric Legius),0.85,Accept,Experimental Usage,90-8
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,90-8 and the sporadic MPNST-derived STS-26T (provided by Dr Eric Legius),0.9,Accept,Experimental Usage,STS-26T
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,sporadic HS-Sch-2 (obtained from RIKEN),0.9,Accept,Experimental Usage,HS-Sch-2
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,the commercial human foreskin fibroblast (HFF) cell line CCD-1112Sk (ATCC),0.9,Accept,Experimental Usage,CCD-1112Sk
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The expression plasmids were transformed into the Rosetta2(DE3) competent cells (EMD Biosciences, Inc)",0.85,Accept,Experimental Usage,Rosetta2(DE3) competent cells
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1 and normal human Schwann cells were obtained and maintained as described",0.9,Accept,Experimental Usage,STS26T
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1 and normal human Schwann cells were obtained and maintained as described",0.9,Accept,Experimental Usage,ST8814
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1 and normal human Schwann cells were obtained and maintained as described",0.9,Accept,Experimental Usage,ST88-3
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1 and normal human Schwann cells were obtained and maintained as described",0.9,Accept,Experimental Usage,S462
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1 and normal human Schwann cells were obtained and maintained as described",0.9,Accept,Experimental Usage,T265p21
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1 and normal human Schwann cells were obtained and maintained as described",0.9,Accept,Experimental Usage,S520
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1 and normal human Schwann cells were obtained and maintained as described",0.9,Accept,Experimental Usage,90–8
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,"MPNST cell lines STS26T, ST8814, ST88-3 S462, T265p21, S520, 90–8, and YST1 and normal human Schwann cells were obtained and maintained as described",0.9,Accept,Experimental Usage,YST1
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,Mice were injected s.c. with a stably transfected DS-red STS26T cell line,0.9,Accept,Experimental Usage,DS-red STS26T cell line
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,expression and activity of catalytically active and inactive PDE4A1 constructs were determined first in Daoy medulloblastoma cells (American Type Culture Collection),0.85,Accept,Experimental Usage,Daoy medulloblastoma cells
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Human MPNST cell lines JH-2-002 and JH-2-103 were obtained from the Johns Hopkins NF1 Biospecimen Repository,0.9,Accept,Experimental Usage,JH-2-002
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Human MPNST cell lines JH-2-002 and JH-2-103 were obtained from the Johns Hopkins NF1 Biospecimen Repository,0.9,Accept,Experimental Usage,JH-2-103
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,ST-8814 and S462 cells were obtained from Dr. Andrew Tee (Cardiff University),0.9,Accept,Experimental Usage,ST-8814
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,ST-8814 and S462 cells were obtained from Dr. Andrew Tee (Cardiff University),0.9,Accept,Experimental Usage,S462
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Immortalized human normal (hTERT ipn02.3 2λ) and NF1 deficient neurofibroma Schwann cells (hTERT NF1 ipNF95.6) were obtained from Dr. Peggy Wallace,0.85,Accept,Experimental Usage,hTERT ipn02.3 2λ
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Immortalized human normal (hTERT ipn02.3 2λ) and NF1 deficient neurofibroma Schwann cells (hTERT NF1 ipNF95.6) were obtained from Dr. Peggy Wallace,0.85,Accept,Experimental Usage,hTERT NF1 ipNF95.6
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,...the reference (ref) cell line was ipnNF95.11C...The reference ipnNF95.11C cell line is derived from the non-tumor peripheral nerve of an NF1 patient...,0.9,Accept,Experimental Usage,ipnNF95.11C
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...the NF1−/− plexiform neurofibroma cell lines (PNF1 cells) ipNF05.5-MX, ipNF06.2A, ipNF95.11b C/T, and ipNF95.6 as test lines...",0.9,Accept,Experimental Usage,ipNF05.5-MX
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...the NF1−/− plexiform neurofibroma cell lines (PNF1 cells) ipNF05.5-MX, ipNF06.2A, ipNF95.11b C/T, and ipNF95.6 as test lines...",0.9,Accept,Experimental Usage,ipNF06.2A
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...the NF1−/− plexiform neurofibroma cell lines (PNF1 cells) ipNF05.5-MX, ipNF06.2A, ipNF95.11b C/T, and ipNF95.6 as test lines...",0.9,Accept,Experimental Usage,ipNF95.11b C/T
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...the NF1−/− plexiform neurofibroma cell lines (PNF1 cells) ipNF05.5-MX, ipNF06.2A, ipNF95.11b C/T, and ipNF95.6 as test lines...",0.9,Accept,Experimental Usage,ipNF95.6
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...additional neurofibromin-competent cell lines, specifically human foreskin fibroblasts [HFF] and the Schwann cell lines ipNF02.3 2λ, ipNF02.8...",0.85,Accept,Experimental Usage,ipNF02.3 2λ
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...additional neurofibromin-competent cell lines, specifically human foreskin fibroblasts [HFF] and the Schwann cell lines ipNF02.3 2λ, ipNF02.8...",0.85,Accept,Experimental Usage,ipNF02.8
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,"By selecting sub-populations of U251 glioblastoma cells, we observed that high expression of phosphorylated Merlin...",0.9,Accept,Experimental Usage,U251
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"The expression vector was transfected into HeLa cells (Lipofectamine LTX with Plus Reagent, Invitrogen)",0.9,Accept,Experimental Usage,HeLa cells
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,"NF90-8 and ST88-14 MPNST cell lines were generously donated by T. Glover (University of Michigan, Ann Arbor, MI). Cells were maintained as adherent cultures in RPMI 1640",0.95,Accept,Experimental Usage,NF90-8
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,"NF90-8 and ST88-14 MPNST cell lines were generously donated by T. Glover (University of Michigan, Ann Arbor, MI). Cells were maintained as adherent cultures in RPMI 1640",0.95,Accept,Experimental Usage,ST88-14
PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,,C6 rat glioma cells were injected into the optic nerve of Long-Evans rats and allowed to proliferate for 2 weeks,0.9,Accept,Experimental Usage,C6 rat glioma cells
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"PDX cells and the MPNST cell line, ST88-14 (gift from Dr. Nancy Ratner, PhD, University of Cincinnati)",0.85,Accept,Experimental Usage,ST88-14
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,based on the use of Nf1(flox/flox) bone marrow stromal cells showed that loss of Nf1 impairs osteoprogenitor cell differentiation,0.85,Accept,Experimental Usage,Nf1flox/flox bone marrow stromal cells
PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,"The fusion proteins, MBP-merlin-N and MBP-merlin-C, were expressed in the DH5α bacteria and purified using the amylose resin",0.85,Accept,Experimental Usage,DH5α bacteria
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,The first direct lineage conversion of post-mitotic neurons from mouse embryonic fibroblasts (MEFs) and tail-tip fibroblasts (TTFs),0.8,Accept,Experimental Usage,mouse embryonic fibroblasts (MEFs)
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,The first direct lineage conversion of post-mitotic neurons from mouse embryonic fibroblasts (MEFs) and tail-tip fibroblasts (TTFs),0.8,Accept,Experimental Usage,tail-tip fibroblasts (TTFs)
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,the availability of NF1 patient-derived induced pluripotent stem cells (iPSCs) provides new opportunities to define the critical factors that underlie NF1-associated nervous system disease,0.95,Accept,Experimental Usage,NF1 patient-derived induced pluripotent stem cells (iPSCs)
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,Bone marrow derived mast cells (BMMCs) were generated from 6-week-old mice as described previously,0.85,Accept,Experimental Usage,Bone marrow derived mast cells (BMMCs)
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,fibroblasts were transduced with supernatants of GP+E86 or GP+AM12 packaging cells in the presence of polybrene,0.8,Accept,Experimental Usage,GP+E86 packaging cells
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,fibroblasts were transduced with supernatants of GP+E86 or GP+AM12 packaging cells in the presence of polybrene,0.8,Accept,Experimental Usage,GP+AM12 packaging cells
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,Proteins were expressed in BL21 (DE3) E.coli and purified using Amersham HiTrap glutathione columns on an AKTA-FPLC,0.9,Accept,Experimental Usage,BL21 (DE3) E.coli
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"H929, U266B1, U2932, MCF7, and HT229 cell lines were selected based on historic demonstrations of their dependences on corresponding BCL-2-family members",0.9,Accept,Experimental Usage,H929
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"H929, U266B1, U2932, MCF7, and HT229 cell lines were selected based on historic demonstrations of their dependences on corresponding BCL-2-family members",0.9,Accept,Experimental Usage,U266B1
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"H929, U266B1, U2932, MCF7, and HT229 cell lines were selected based on historic demonstrations of their dependences on corresponding BCL-2-family members",0.9,Accept,Experimental Usage,U2932
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"H929, U266B1, U2932, MCF7, and HT229 cell lines were selected based on historic demonstrations of their dependences on corresponding BCL-2-family members",0.9,Accept,Experimental Usage,MCF7
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"H929, U266B1, U2932, MCF7, and HT229 cell lines were selected based on historic demonstrations of their dependences on corresponding BCL-2-family members",0.9,Accept,Experimental Usage,HT229
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"Except for MCF7, HT229, and HCC1937 (gifts from Dr. Bora Limb, MD Anderson Cancer Research Center, Houston, TX, USA), all cell lines were purchased from the American Type Culture Collection",0.9,Accept,Experimental Usage,HCC1937
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1",0.9,Accept,Experimental Usage,T265
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1",0.9,Accept,Experimental Usage,S462
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1",0.9,Accept,Experimental Usage,NSF1
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"T462 and T265 cells were initially provided by Victor Mautner (University of Hamburg, Germany)",0.9,Accept,Experimental Usage,T462
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,BRGN control cells used in this study were previously described,0.85,Accept,Experimental Usage,BRGN
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"The primary human Schwann cells (HSC) were obtained by ScienCell (#1700, Carlsbad, CA, USA)",0.9,Accept,Experimental Usage,primary human Schwann cells (HSC)
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"The S462TY cell line was a kind gift from Dr. Timothy Cripe (Nationwide Children's Hospital Columbus, Columbus, OH, USA)",0.9,Accept,Experimental Usage,S462TY
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"The MPNST cell lines STS26T, T265, and ST8814 have been reported before and were gifted by Dr. Nancy Ratner",0.9,Accept,Experimental Usage,STS26T
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"The MPNST cell lines STS26T, T265, and ST8814 have been reported before and were gifted by Dr. Nancy Ratner",0.9,Accept,Experimental Usage,T265
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"The MPNST cell lines STS26T, T265, and ST8814 have been reported before and were gifted by Dr. Nancy Ratner",0.9,Accept,Experimental Usage,ST8814
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"Normal human Schwann cells (HSC) (ScienCell Research Laboratories, Carlsbad, CA, USA) were grown on the poly-L-lysine-coated tissue culture plates",0.85,Accept,Experimental Usage,Normal human Schwann cells (HSC)
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Human MPNST cell lines (S462, T265, and NSF1) were analyzed and have been described in detail in our previous studies",0.9,Accept,Experimental Usage,S462
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Human MPNST cell lines (S462, T265, and NSF1) were analyzed and have been described in detail in our previous studies",0.9,Accept,Experimental Usage,T265
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Human MPNST cell lines (S462, T265, and NSF1) were analyzed and have been described in detail in our previous studies",0.9,Accept,Experimental Usage,NSF1
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Mouse fibroblast B8 cells (kindly provided by Ralf Stohwasser, Brandenburg Technical University Cottbus-Senftenberg) which were stably transfected",0.85,Accept,Experimental Usage,B8 fibroblasts
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,NF1−/− S462-TY human MPNST xenograft model has been previously described,0.95,Accept,Experimental Usage,S462-TY
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Greater than 50% inhibition of OVCAR8, HEY, and ID8-IP ovarian carcinoma cell growth occurred with 0.1 μM PF-271",0.9,Accept,Experimental Usage,OVCAR8
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Greater than 50% inhibition of OVCAR8, HEY, and ID8-IP ovarian carcinoma cell growth occurred with 0.1 μM PF-271",0.9,Accept,Experimental Usage,HEY
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Greater than 50% inhibition of OVCAR8, HEY, and ID8-IP ovarian carcinoma cell growth occurred with 0.1 μM PF-271",0.9,Accept,Experimental Usage,ID8-IP
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Suspended growth of OVCAR3, OVCAR10, IGROV1, IGROV1-IP, SKOV3, SKOV3-IP, A2780, and 5009-MOVCAR was not affected by 0.1 μM PF-271",0.9,Accept,Experimental Usage,OVCAR3
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Suspended growth of OVCAR3, OVCAR10, IGROV1, IGROV1-IP, SKOV3, SKOV3-IP, A2780, and 5009-MOVCAR was not affected by 0.1 μM PF-271",0.9,Accept,Experimental Usage,OVCAR10
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Suspended growth of OVCAR3, OVCAR10, IGROV1, IGROV1-IP, SKOV3, SKOV3-IP, A2780, and 5009-MOVCAR was not affected by 0.1 μM PF-271",0.9,Accept,Experimental Usage,IGROV1
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Suspended growth of OVCAR3, OVCAR10, IGROV1, IGROV1-IP, SKOV3, SKOV3-IP, A2780, and 5009-MOVCAR was not affected by 0.1 μM PF-271",0.9,Accept,Experimental Usage,IGROV1-IP
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Suspended growth of OVCAR3, OVCAR10, IGROV1, IGROV1-IP, SKOV3, SKOV3-IP, A2780, and 5009-MOVCAR was not affected by 0.1 μM PF-271",0.9,Accept,Experimental Usage,SKOV3
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Suspended growth of OVCAR3, OVCAR10, IGROV1, IGROV1-IP, SKOV3, SKOV3-IP, A2780, and 5009-MOVCAR was not affected by 0.1 μM PF-271",0.9,Accept,Experimental Usage,SKOV3-IP
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Suspended growth of OVCAR3, OVCAR10, IGROV1, IGROV1-IP, SKOV3, SKOV3-IP, A2780, and 5009-MOVCAR was not affected by 0.1 μM PF-271",0.9,Accept,Experimental Usage,A2780
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,"Suspended growth of OVCAR3, OVCAR10, IGROV1, IGROV1-IP, SKOV3, SKOV3-IP, A2780, and 5009-MOVCAR was not affected by 0.1 μM PF-271",0.9,Accept,Experimental Usage,5009-MOVCAR
PMID:24786638,10.1016/j.ygyno.2014.04.044,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,,MOVCAR-5009 cells were isolated from the ascites of transgenic mice expressing simian virus 40 T antigen (TAg) driven by the Müllerian inhibitory substance type II receptor (MISIIR) gene promoter,0.9,Accept,Experimental Usage,MOVCAR-5009
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,We measured the migratory response of 8814 MPNST cells using a modified Boyden chamber assay. Cells (4 × 10 4 ) in serum-free DMEM were plated...,0.85,Accept,Experimental Usage,8814 MPNST cells
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,Human umbilical vascular endothelial cells (HUVEC) were purchased from Lonza. HUVECs maintained in EBM2 medium...,0.8,Accept,Experimental Usage,Human umbilical vascular endothelial cells (HUVEC)
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"We received iHSCs from Dr Margaret Wallace (University of Florida, Gainesville). These are wild-type human neonatal SCs immortalized using the human reverse transcriptase component of telomerase (hTERT)",0.85,Accept,Experimental Usage,iHSCs
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,We also utilized immortalized PN hTERT NF1 ipNF95.6 (iPNF) and MPNST cell lines (sNF96.2 and sNF02.2) from American Type Culture Collection (ATCC),0.9,Accept,Experimental Usage,iPNF95.6
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,We also utilized immortalized PN hTERT NF1 ipNF95.6 (iPNF) and MPNST cell lines (sNF96.2 and sNF02.2) from American Type Culture Collection (ATCC),0.9,Accept,Experimental Usage,sNF96.2
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,We also utilized immortalized PN hTERT NF1 ipNF95.6 (iPNF) and MPNST cell lines (sNF96.2 and sNF02.2) from American Type Culture Collection (ATCC),0.9,Accept,Experimental Usage,sNF02.2
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"Other MPNST cell lines and patient-derived xenografts (PDX) were kindly provided by Dr Nancy Ratner (Cincinnati Children's Hospital) (26T, S462TY, ST88-14, MPNST724)",0.85,Accept,Experimental Usage,26T
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"Other MPNST cell lines and patient-derived xenografts (PDX) were kindly provided by Dr Nancy Ratner (Cincinnati Children's Hospital) (26T, S462TY, ST88-14, MPNST724)",0.85,Accept,Experimental Usage,S462TY
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"Other MPNST cell lines and patient-derived xenografts (PDX) were kindly provided by Dr Nancy Ratner (Cincinnati Children's Hospital) (26T, S462TY, ST88-14, MPNST724)",0.85,Accept,Experimental Usage,ST88-14
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"the Characterized Cell Line Core Facility (MD Anderson) (MPNST007), and Dr Christine Pratilas (Johns Hopkins) (JH-2-055 CL, JH-2-079c CL, JH-2-003 CL, JH-2-002 CL)",0.85,Accept,Experimental Usage,MPNST007
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"and Dr Christine Pratilas (Johns Hopkins) (JH-2-055 CL, JH-2-079c CL, JH-2-003 CL, JH-2-002 CL)",0.85,Accept,Experimental Usage,JH-2-055 CL
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"and Dr Christine Pratilas (Johns Hopkins) (JH-2-055 CL, JH-2-079c CL, JH-2-003 CL, JH-2-002 CL)",0.85,Accept,Experimental Usage,JH-2-079c CL
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"and Dr Christine Pratilas (Johns Hopkins) (JH-2-055 CL, JH-2-079c CL, JH-2-003 CL, JH-2-002 CL)",0.85,Accept,Experimental Usage,JH-2-003 CL
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"and Dr Christine Pratilas (Johns Hopkins) (JH-2-055 CL, JH-2-079c CL, JH-2-003 CL, JH-2-002 CL)",0.85,Accept,Experimental Usage,JH-2-002 CL
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"CUTLL1 was used as positive controls for NOTCH1, MDA-MB-231 for NOTCH1, NOTCH2, and NOTCH4, and MCF7 for HES1 and NOTCH3",0.8,Accept,Experimental Usage,CUTLL1
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"CUTLL1 was used as positive controls for NOTCH1, MDA-MB-231 for NOTCH1, NOTCH2, and NOTCH4, and MCF7 for HES1 and NOTCH3",0.8,Accept,Experimental Usage,MDA-MB-231
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"CUTLL1 was used as positive controls for NOTCH1, MDA-MB-231 for NOTCH1, NOTCH2, and NOTCH4, and MCF7 for HES1 and NOTCH3",0.8,Accept,Experimental Usage,MCF7
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Transient models of SUZ12 loss were created in iPNF and N0(32) cells using SUZ12 siRNA (5 nmol),0.8,Accept,Experimental Usage,N0(32)
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,"U87-MG, U251-MG, and sNF96.2 cells were purchased from ATCC...U87-MG cells serve as an NF1-deficient tumor cell line model",0.9,Accept,Experimental Usage,U87-MG
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,"U87-MG, U251-MG, and sNF96.2 cells were purchased from ATCC",0.9,Accept,Experimental Usage,U251-MG
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,"U87-MG, U251-MG, and sNF96.2 cells were purchased from ATCC",0.95,Accept,Experimental Usage,sNF96.2
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,"ipnNF95.11C and ipNF95.11b 'C' cells were kindly provided by Peggy Wallace, University of Florida, USA and are available for purchase through the ATCC",0.95,Accept,Experimental Usage,ipnNF95.11C
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,"ipnNF95.11C and ipNF95.11b 'C' cells were kindly provided by Peggy Wallace, University of Florida, USA and are available for purchase through the ATCC",0.95,Accept,Experimental Usage,ipNF95.11b 'C'
PMID:25877069,10.1007/s11626-015-9885-z,Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.,,"Furthermore, we generated a novel murine mesothelioma cell line RN5 originating from an Nf2+/- mouse subjected to repeated crocidolite exposure. RN5 cells are highly tumorigenic.",0.95,Accept,Development,RN5
PMID:25877069,10.1007/s11626-015-9885-z,Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.,,"the MM cell line RN5, and the previously described murine MM cell line AK7 (Cordier Kellerman et al. 2003), the latter also on a C57Bl/6J background.",0.85,Accept,Experimental Usage,AK7
PMID:33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,,PC12 cells (ATCC CRL-1721) were grown on Collagen IV-coated dishes (25 μg/ml) and maintained in RPMI 1640 medium,0.95,Accept,Experimental Usage,PC12 cells (ATCC CRL-1721)
PMID:33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,,"H19-7/IGF-IR (ATCC CRL-2526) were maintained in DMEM supplemented with 10% fetal bovine serum, 200 mg/ml of G418",0.95,Accept,Experimental Usage,H19-7/IGF-IR (ATCC CRL-2526)
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,STS26T and T265 cells were routinely maintained in DMEM high-glucose medium (Invitrogen 11965-092) with 10% FBS,0.9,Accept,Experimental Usage,STS26T
PMID:21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,,STS26T and T265 cells were routinely maintained in DMEM high-glucose medium (Invitrogen 11965-092) with 10% FBS,0.9,Accept,Experimental Usage,T265
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,"Human glioma cells, M089J, U138MG, DBRG05MG, LN229, M059K, Hs683, LN18, LN229, and A172 cells were obtained from American Type Culture Collection (ATCC)",0.85,Accept,Experimental Usage,M089J
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,"Human glioma cells, M089J, U138MG, DBRG05MG, LN229, M059K, Hs683, LN18, LN229, and A172 cells were obtained from American Type Culture Collection (ATCC)",0.85,Accept,Experimental Usage,U138MG
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,U87MG and U251 human glioma cells were first transduced with retroviruses carrying luciferase and a hygromycin-resistant gene,0.9,Accept,Experimental Usage,U87MG
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,U87MG and U251 human glioma cells were first transduced with retroviruses carrying luciferase and a hygromycin-resistant gene,0.9,Accept,Experimental Usage,U251
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,rat glioma cell 9L were obtained from University of California-San Francisco and National Cancer Institute (NCI),0.8,Accept,Experimental Usage,9L
PMID:26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",,HEK293T cells were cultured under standard conditions...HEK293T cells were transiently transfected with pcDNA3-Pyo-mKSR1-wt,0.85,Accept,Experimental Usage,HEK293T cells
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Patient-derived iPN, neurofibroma (NF95.11b), or human MPNST (JH002-2, ST88-14) cell lines",0.85,Accept,Experimental Usage,iPN cells
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Patient-derived iPN, neurofibroma (NF95.11b), or human MPNST (JH002-2, ST88-14) cell lines",0.9,Accept,Experimental Usage,NF95.11b
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Patient-derived iPN, neurofibroma (NF95.11b), or human MPNST (JH002-2, ST88-14) cell lines",0.9,Accept,Experimental Usage,JH002-2
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Patient-derived iPN, neurofibroma (NF95.11b), or human MPNST (JH002-2, ST88-14) cell lines",0.9,Accept,Experimental Usage,ST88-14
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Mouse MPNST cell lines (JW18.2, JW23.3) were a gift from Angie Hirbe",0.9,Accept,Experimental Usage,JW18.2
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"Mouse MPNST cell lines (JW18.2, JW23.3) were a gift from Angie Hirbe",0.9,Accept,Experimental Usage,JW23.3
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,Immortalized murine Nf1-negative and wild type mouse embryonic fibroblasts (MEF Nf1−/− E1A-p53 and MEF Nf1wt E1A-p53) were generously provided by Dr. Karen Cichowski,0.9,Accept,Experimental Usage,MEF Nf1−/− E1A-p53
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,Immortalized murine Nf1-negative and wild type mouse embryonic fibroblasts (MEF Nf1−/− E1A-p53 and MEF Nf1wt E1A-p53) were generously provided by Dr. Karen Cichowski,0.9,Accept,Experimental Usage,MEF Nf1wt E1A-p53
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"MPNST cell lines sNF96.2, sNF02.2 and sNF94.3 were obtained from the American Type Culture Collection",0.95,Accept,Experimental Usage,sNF96.2
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"MPNST cell lines sNF96.2, sNF02.2 and sNF94.3 were obtained from the American Type Culture Collection",0.95,Accept,Experimental Usage,sNF02.2
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"MPNST cell lines sNF96.2, sNF02.2 and sNF94.3 were obtained from the American Type Culture Collection",0.95,Accept,Experimental Usage,sNF94.3
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"S462TY cells were generously provided by Dr. Timothy Cripe (Nationwide Children's Hospital, OH)",0.95,Accept,Experimental Usage,S462TY
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"ST8814, ST88-3 and 90-8 were generously provided by Dr. Nancy Ratner (Cincinnati Children's Hospital, OH)",0.95,Accept,Experimental Usage,ST8814
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"ST8814, ST88-3 and 90-8 were generously provided by Dr. Nancy Ratner (Cincinnati Children's Hospital, OH)",0.95,Accept,Experimental Usage,ST88-3
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"ST8814, ST88-3 and 90-8 were generously provided by Dr. Nancy Ratner (Cincinnati Children's Hospital, OH)",0.95,Accept,Experimental Usage,90-8
PMID:19427294,10.1016/j.stem.2009.03.017,Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.,,we identify a population of stem/progenitor cells residing in the dermis termed skin-derived precursors (SKPs),0.85,Accept,Experimental Usage,skin-derived precursors (SKPs)
PMID:19427294,10.1016/j.stem.2009.03.017,Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.,,Western blotting on lysates of SKPs and 3T3 cells with Dhh antibody,0.8,Accept,Experimental Usage,3T3 cells
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,"...human MPM patient derived xenografts, MSTO-211H, MDA-MB-468 and MDA-MB-231 s.c. xenograft experiments...",0.85,Accept,Experimental Usage,MSTO-211H
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,"...human MPM patient derived xenografts, MSTO-211H, MDA-MB-468 and MDA-MB-231 s.c. xenograft experiments...",0.8,Accept,Experimental Usage,MDA-MB-468
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,"...human MPM patient derived xenografts, MSTO-211H, MDA-MB-468 and MDA-MB-231 s.c. xenograft experiments...",0.8,Accept,Experimental Usage,MDA-MB-231
PMID:19041782,10.1016/j.stem.2008.10.003,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,,We produced lentivirus particles encoding GFP by transient co-transfection of 293T cells,0.8,Accept,Experimental Usage,293T cells
PMID:29137242,10.18632/oncotarget.18301,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,,The human NF1−/− MPNST cell line S462TY and NF1+/ human sporadic MPNST STS-26T cell line have been previously described,0.9,Accept,Experimental Usage,S462TY
PMID:29137242,10.18632/oncotarget.18301,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,,The human NF1−/− MPNST cell line S462TY and NF1+/ human sporadic MPNST STS-26T cell line have been previously described,0.9,Accept,Experimental Usage,STS-26T
PMID:29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,,"U87-MG cells were purchased from ATCC (Manassas, VA). U251-MG cells were purchased from Sigma-Aldrich. U87-MG and U251-MG were passaged regularly and cultured with DMEM",0.9,Accept,Experimental Usage,U87-MG
PMID:29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,,"U87-MG cells were purchased from ATCC (Manassas, VA). U251-MG cells were purchased from Sigma-Aldrich. U87-MG and U251-MG were passaged regularly and cultured with DMEM",0.9,Accept,Experimental Usage,U251-MG
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"Establishment of the YST-1 ( Nagashima et al., 1990 ), STS-26T ( Dahlberg et al., 1993 ) and ST88-14 ( Ryan et al., 1994 ) human MPNST cell lines",0.9,Accept,Experimental Usage,YST-1
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"Establishment of the YST-1 ( Nagashima et al., 1990 ), STS-26T ( Dahlberg et al., 1993 ) and ST88-14 ( Ryan et al., 1994 ) human MPNST cell lines",0.9,Accept,Experimental Usage,STS-26T
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"Establishment of the YST-1 ( Nagashima et al., 1990 ), STS-26T ( Dahlberg et al., 1993 ) and ST88-14 ( Ryan et al., 1994 ) human MPNST cell lines",0.9,Accept,Experimental Usage,ST88-14
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"The murine A202, B76 and B97 cell lines were established from MPNSTs arising in P 0 -GGFβ3 mice",0.9,Accept,Experimental Usage,A202
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"The murine A202, B76 and B97 cell lines were established from MPNSTs arising in P 0 -GGFβ3 mice",0.9,Accept,Experimental Usage,B76
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"The murine A202, B76 and B97 cell lines were established from MPNSTs arising in P 0 -GGFβ3 mice",0.9,Accept,Experimental Usage,B97
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,Biological activity of NRG-1β and NRG-1α was verified by demonstrating that nanomolar concentrations of these recombinant proteins maximally stimulated erbB phosphorylation in MCF-7 breast carcinoma cells,0.8,Accept,Experimental Usage,MCF-7 breast carcinoma cells
PMID:18931645,10.1097/MAO.0b013e31818b6cea,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,,"Lentiviruses were generated by cotransfection of 293T cells with 3 plasmids: gag-pol, env, and pHR-SIN-CSGW dlNotI-luciferase",0.8,Accept,Experimental Usage,293T cells
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,"Human hTERT ipn02.3 2l SCs (""02.3"") were obtained from American Type Culture Collection (CRL-3392)",0.9,Accept,Experimental Usage,hTERT ipn02.3 2l SCs
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,HEI-193 schwannoma (RRID:CVCL_7660) and murine (MS03 schwannoma) cell lines were generated as previously described,0.9,Accept,Experimental Usage,HEI-193 schwannoma cell line
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,HEI-193 schwannoma (RRID:CVCL_7660) and murine (MS03 schwannoma) cell lines were generated as previously described,0.9,Accept,Experimental Usage,MS03 schwannoma cell line
PMID:18927496,10.4161/cbt.7.12.6942,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,,"Human MPNST cell lines ST88-14 and NF90-8 (generous gifts from T. Glover, University of Michigan, Ann Arbor, MI, U.S.A.)",0.9,Accept,Experimental Usage,ST88-14
PMID:18927496,10.4161/cbt.7.12.6942,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,,"Human MPNST cell lines ST88-14 and NF90-8 (generous gifts from T. Glover, University of Michigan, Ann Arbor, MI, U.S.A.)",0.9,Accept,Experimental Usage,NF90-8
PMID:18927496,10.4161/cbt.7.12.6942,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,,"and STS-26T (a generous gift from D. Scoles, Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.) were cultured in RPMI",0.9,Accept,Experimental Usage,STS-26T
